James S Butler

Author PubWeight™ 14.09^‹?›

Rank	Title	Journal	Year	PubWeight™‹?›
1	Safety and efficacy of RNAi therapy for transthyretin amyloidosis.	N Engl J Med	2013	3.97
2	Targeted delivery of RNAi therapeutics with endogenous and exogenous ligand-based mechanisms.	Mol Ther	2010	3.26
3	Dynamics of equilibrium structural fluctuations of apomyoglobin measured by fluorescence correlation spectroscopy.	Proc Natl Acad Sci U S A	2007	1.18
4	Modular enzyme design: regulation by mutually exclusive protein folding.	J Mol Biol	2006	1.14
5	Harnessing a physiologic mechanism for siRNA delivery with mimetic lipoprotein particles.	Mol Ther	2012	1.04
6	Bacteriophage P22 tail accessory factor GP26 is a long triple-stranded coiled-coil.	J Biol Chem	2004	1.03
7	Folding of tetrameric p53: oligomerization and tumorigenic mutations induce misfolding and loss of function.	J Mol Biol	2009	1.00
8	Clinical outcomes in extracranial tumor sites and unusual toxicities with concurrent whole brain radiation (WBRT) and Erlotinib treatment in patients with non-small cell lung cancer (NSCLC) with brain metastasis.	Lung Cancer	2010	0.90
9	Combination therapy with a Tmprss6 RNAi-therapeutic and the oral iron chelator deferiprone additively diminishes secondary iron overload in a mouse model of β-thalassemia intermedia.	Am J Hematol	2015	0.89